What the 2026 Hemp Law Means for Bulk CBD and Non-Intoxicating Cannabinoid Buyers
Section 781 of P.L. 119-37 takes effect on November 12, 2026, and it changes the federal hemp definition in ways that affect every business operating in the hemp cannabinoid supply chain. For B2B buyers of bulk CBD, CBG, CBN, CBC, and CBDV — the non-intoxicating cannabinoids — the practical news is favorable: these cannabinoids remain within the federal hemp definition after November 12. The changes hit intoxicating hemp-derived products. This guide explains exactly what changes, what stays legal, and the critical distinction between bulk B2B ingredients and finished consumer products that every hemp industry operator needs to understand before that date.
What Is Section 781 of P.L. 119-37?
P.L. 119-37 is the federal law containing Section 781, which amends the definition of hemp to exclude cannabinoids that produce intoxicating effects. It targets the synthetic, converted, and high-potency intoxicating cannabinoid products that proliferated after the 2018 Farm Bill. The effective date is November 12, 2026. For non-intoxicating cannabinoid businesses — CBD, CBG, CBN, CBC, CBDV — Section 781 does not change the legal status of these ingredients. They remain explicitly within the federal hemp definition.
What Changes on November 12, 2026?
- Delta-8 THC: removed from the federal hemp definition
- Delta-10 THC and synthetic THC analogs: excluded
- THCA flower and concentrates: outside the updated definition
- HHC, THCP, THC-O, and similar compounds: excluded
- High-THC finished consumer products: products containing more than 0.4 milligrams of total THC per container exit the hemp definition
What Stays Legal After November 12, 2026?
- CBD (cannabidiol): all bulk formats — isolate, distillate, broad-spectrum, full-spectrum, crude oil, water-soluble
- CBG (cannabigerol): isolate, distillate, flower, and biomass
- CBN (cannabinol): generally understood to remain legal as a naturally occurring, minimally intoxicating cannabinoid. Note that FDA has not yet published its similar-effects list; CBN’s status will be confirmed once that list is published.
- CBC (cannabichromene): isolate and distillate. Non-intoxicating, unaffected.
- CBDV (cannabidivarin): isolate and distillate. Non-intoxicating.
- CBDA and CBGA: the acidic precursor forms. Non-intoxicating, unaffected.
- Hemp terpenes: entirely unaffected. Terpenes are not cannabinoids.
- Hemp biomass: Farm Bill-compliant biomass at or below 0.3% total THC remains legal.
The Critical B2B Bulk Ingredient Distinction
For B2B buyers purchasing bulk hemp cannabinoid ingredients, the most important point in Section 781 is this: the law distinguishes between bulk raw ingredients and finished consumer products. The 0.3% total THC threshold on hemp biomass and bulk extracts remains unchanged. B2B buyers sourcing bulk CBD, CBG, or other non-intoxicating cannabinoid ingredients face no change in the compliance standard for those ingredients after November 12, 2026.
What the 0.4mg Container Cap Means for Finished Products
Section 781 introduces a per-container total THC cap of 0.4 milligrams for finished hemp-derived consumer products. This applies to the total THC content in the complete finished product — not to the bulk ingredient. Manufacturers formulating with full-spectrum CBD distillate should calculate total THC per container for each finished SKU and determine whether reformulation is needed before November 12, 2026. For manufacturers formulating with broad-spectrum CBD distillate or CBD isolate — both non-detect THC — the 0.4 mg cap is not a constraint.
From the Field
“I have been in this industry since the first year of Farm Bill legalization, and Section 781 is the clearest regulatory signal I have seen in seven years. It is not ambiguous. It is not likely to be reversed. The companies that built on intoxicating hemp-derived products — Delta-8, THCA, HHC — need to be rebuilding their product lines on the cannabinoids that remain legal right now, not waiting to see how things develop. The window is shorter than most operators realize. The companies that will be standing after November 12, 2026 are the ones that treated this as a hard deadline and prepared accordingly — tightened their operations, shored up their supplier relationships, and rebuilt their product lines on CBD, CBG, CBN, and the other non-intoxicating cannabinoids. BCD has been positioned here since 2021. We built the company around exactly these cannabinoids for exactly this reason.”
— John Piccone, Founder, Bulk CBD Distributors
Source Section 781-Compliant Cannabinoids from BCD
BCD’s catalog is built around non-intoxicating cannabinoids that remain within the federal hemp definition after November 12, 2026. All products include hemp compliance statements. Contact our sales team to discuss your post-November sourcing requirements.
BCD’s Product Catalog After November 2026
BCD’s focus on non-intoxicating cannabinoids means the catalog is largely unchanged by Section 781. The following remain fully available after November 12, 2026:
- CBD: CBD isolate, full-spectrum distillate, broad-spectrum distillate, CBD crude oil, water-soluble CBD
- CBG: CBG isolate, CBG distillate, CBG flower, CBG biomass
- CBN: CBN isolate, CBN distillate
- CBC: CBC isolate, CBC distillate
- CBDV: CBDV isolate, CBDV distillate
- Acidic cannabinoids: CBDA isolate, CBGA isolate
- Hemp terpenes and biomass: unaffected by Section 781
BCD does not carry Delta-8 THC, THCP, HHC, THC-O, or other intoxicating hemp-derived products. The company’s strategic focus has been non-intoxicating cannabinoids from the outset.
What B2B Buyers Should Do Before November 2026
- Audit your current ingredient inventory for any bulk ingredients containing Delta-8 THC, THCA, or other Section 781-affected cannabinoids.
- Calculate total THC in finished products for any full-spectrum CBD distillate formulations. Products exceeding 0.4 mg THC per container need reformulation.
- Review supplier documentation to ensure current-lot COAs confirm Farm Bill compliance with the correct total THC formula.
- Identify replacement ingredients for any affected SKUs — CBD, CBG, CBN, CBC, and CBDV are the compliant substitutes.
- Update labels and marketing materials referencing the legal status of affected cannabinoids before November 12.
What This Means for Your Business
Section 781 is the clearest regulatory signal the hemp industry has received: the future of federally legal hemp cannabinoids is non-intoxicating. Businesses positioned on CBD, CBG, CBN, CBC, and CBDV face no disruption. Businesses still carrying intoxicating hemp products face a hard transition deadline. BCD’s wholesale catalog of non-intoxicating cannabinoids is fully positioned for the post-November market. Contact our sales team to discuss your November 2026 transition plan.
Plan Your Post-November 2026 Supply Chain with BCD
BCD’s non-intoxicating cannabinoid catalog — CBD, CBG, CBN, CBC, CBDV, and related formats — remains fully compliant after Section 781 takes effect. All products include hemp compliance documentation. USA-manufactured and distributed.
Frequently Asked Questions
What is Section 781 of P.L. 119-37?
Section 781 amends the definition of hemp to exclude intoxicating hemp-derived cannabinoids, effective November 12, 2026. It removes Delta-8 THC, Delta-10 THC, THCA, HHC, and similar compounds from the federal hemp definition while preserving non-intoxicating cannabinoids including CBD, CBG, CBN, CBC, and CBDV.
When does Section 781 take effect?
November 12, 2026. Products and ingredients outside the updated hemp definition must be brought into compliance before that date.
Is CBD legal after November 12, 2026?
Yes. CBD remains federally legal after November 12, 2026 as a non-intoxicating cannabinoid within the updated hemp definition, provided it derives from Farm Bill-compliant hemp with total THC at or below 0.3%.
Is CBN legal after November 12, 2026?
CBN is generally understood to remain federally legal after November 12, 2026 as a naturally occurring, minimally intoxicating cannabinoid. The FDA has not yet published its similar-effects list. BCD will address any regulatory update transparently.
What is the 0.4mg total THC container cap?
Section 781 limits finished hemp-derived consumer products to 0.4 milligrams of total THC per container. This cap applies to the total product, not to bulk raw ingredients. Manufacturers using full-spectrum CBD distillate should calculate total THC per container for each finished SKU.
Does the 0.4mg cap affect bulk CBD ingredients purchased from BCD?
No. The cap applies to finished consumer products, not to raw bulk hemp ingredients. The applicable standard for bulk ingredients remains the 0.3% total THC threshold, unchanged by Section 781.
What cannabinoids are removed under Section 781?
Delta-8 THC, Delta-10 THC, THCA (in intoxicating applications), HHC, THCP, THC-O, and other synthesized or converted intoxicating hemp-derived cannabinoids. Non-intoxicating cannabinoids including CBD, CBG, CBN, CBC, and CBDV are not restricted.
Do I need to reformulate my full-spectrum CBD products?
Possibly, depending on total THC per container. Calculate total THC per container (THC percentage x total distillate mass in the product) for each full-spectrum SKU. Products above 0.4 mg THC per container need reformulation to broad-spectrum distillate or CBD isolate before November 12, 2026.
Where should B2B cannabinoid buyers focus after November 2026?
On non-intoxicating cannabinoids with a stable regulatory foundation: CBD, CBG, CBN, CBC, and CBDV in bulk formats. These represent the long-term core of the federally legal hemp ingredient market. Contact BCD to discuss your post-November sourcing strategy.
Related Reading
- How to Source Wholesale CBD: The B2B Buyer’s Complete 2026 Guide
- Full Spectrum vs. Broad Spectrum vs. CBD Isolate: The Definitive B2B Comparison
- Browse BCD’s wholesale CBD catalog
John Piccone
Founder, Bulk CBD Distributors | johnpiccone.com
John Piccone has been active in hemp and CBD since the first year of Farm Bill legalization. Before founding Bulk CBD Distributors in 2021, he helped build two of the early industry’s most significant companies — including a major hemp farming operation that was among the first to grow legally at scale in Puerto Rico and Barcelona, Spain — and contributed to generating a high eight-figure revenue year before those businesses exited the market. BCD has grown into one of the most respected wholesale cannabinoid operations in the US hemp industry, built deliberately small, tactically efficient, and deeply connected across the supply chain. Learn more about BCD.